Antimicrobial Agents Practice Questions

Q: What is the mechanism of action of aminoglycoside antibiotics?

Inhibition of protein synthesis. ***Inhibition of protein synthesis*** - Aminoglycosides **bind irreversibly to the 30S ribosomal subunit** of bacteria, interfering with the initiation complex formation and causing misreading of mRNA. - This leads to the production of **non-functional proteins** and ultimately bacterial cell death, making them bactericidal. *Disruption of the cell membrane* - This mechanism is characteristic of **polymyxins** (e.g., colistin), which interact with bacterial cell membranes, increasing permeability and causing leakage of intracellular contents. - Aminoglycosides do not primarily target the cell membrane for their bactericidal action. *Inhibition of DNA replication* - This mechanism is associated with **fluoroquinolones**, which inhibit bacterial topoisomerase II (DNA gyrase) and topoisomerase IV. - Aminoglycosides do not interfere with DNA synthesis or replication. *Inhibition of bacterial cell wall synthesis* - This is the mechanism of action for **beta-lactam antibiotics** (e.g., penicillins, cephalosporins) and **glycopeptides** (e.g., vancomycin), which target peptidoglycan synthesis. - Aminoglycosides do not affect the bacterial cell wall but rather their intracellular protein machinery.

Q: What is the drug of choice for listeria meningitis?

Ampicillin. ***Ampicillin*** - **Ampicillin** is the **drug of choice** for *Listeria monocytogenes* meningitis due to its excellent in vitro activity and good central nervous system penetration. - It is often used in combination with an **aminoglycoside** (e.g., gentamicin) for synergistic bactericidal activity, especially in severe cases, though gentamicin does not penetrate the CSF well. *Cefotaxime* - **Third-generation cephalosporins** like cefotaxime have poor activity against *Listeria monocytogenes* due to the organism's intrinsic resistance to these agents. - While effective against many other bacterial causes of meningitis (e.g., *S. pneumoniae*, *N. meningitidis*), it is not appropriate for *Listeria*. *Ceftriaxone* - Similar to cefotaxime, **ceftriaxone** is a third-generation cephalosporin and is **ineffective** against *Listeria monocytogenes* due to the lack of penicillin-binding protein (PBP) affinity. - Its use for *Listeria* meningitis would lead to treatment failure. *Ciprofloxacin* - **Ciprofloxacin**, a fluoroquinolone, is generally **not recommended** as a first-line treatment for *Listeria* meningitis, despite some in vitro activity. - Its use is typically reserved for patients with severe allergies to penicillins, and even then, **trimethoprim-sulfamethoxazole** is usually preferred as an alternative to ampicillin.

Q: All of the following are used for treatment of *H. pylori*, except:

Gentamicin. ***Gentamicin*** - **Gentamicin** is an **aminoglycoside antibiotic** primarily used for severe Gram-negative bacterial infections and is **not effective** against *H. pylori*. - Its mechanism of action and **toxicity profile** (ototoxicity, nephrotoxicity) make it unsuitable for typical *H. pylori* eradication regimens. *Clarithromycin* - **Clarithromycin** is a **macrolide antibiotic** frequently used in **triple therapy regimens** for *H. pylori* eradication. - It works by **inhibiting bacterial protein synthesis**, significantly contributing to the eradication of the bacteria. *Metronidazole* - **Metronidazole** is an **antibiotic** and **antiprotozoal agent** commonly included in *H. pylori* **quadruple therapy** or when penicillin allergies are present. - It acts by forming **cytotoxic compounds** that disrupt bacterial DNA, making it effective against anaerobic and microaerophilic bacteria like *H. pylori*. *Amoxicillin* - **Amoxicillin** is a **beta-lactam antibiotic** that is a cornerstone of many *H. pylori* **eradication regimens**, particularly in standard triple therapy. - It works by **inhibiting bacterial cell wall synthesis**, leading to bacterial lysis.

Q: Which of the following medications is not typically used in the treatment of malignant malaria?

Quinolone. ***Quinolone*** - **Quinolone** antibiotics, while broad-spectrum, are not typically used as primary antimalarial agents due to limited efficacy against *Plasmodium falciparum* and potential for resistance. - Their use in malaria treatment is generally restricted to specific co-infections rather than direct antimalarial efficacy. *Quinine* - **Quinine** has been a cornerstone of severe malaria treatment for many years, especially in regions with limited access to newer artemisinin derivatives. - It works by interfering with the parasite's ability to detoxify heme, thus killing the parasites. *Doxycycline* - **Doxycycline** is an effective antimalarial, particularly as a prophylactic agent and in combination therapy for uncomplicated malaria or as an alternative for severe malaria when other agents are contraindicated. - It inhibits **protein synthesis** in the parasite. *Artesunate* - **Artesunate** is the recommended first-line treatment for severe malaria due to its rapid action and potent parasiticidal effects. - It is an **artemisinin derivative** that produces free radicals toxic to the parasite.

Q: What is the drug of choice for malaria in pregnancy?

Chloroquine. ***Chloroquine*** - **Chloroquine** is the drug of choice for **uncomplicated malaria in pregnancy** caused by **chloroquine-sensitive** strains of *P. vivax*, *P. ovale*, *P. malariae*, and *P. falciparum* [1]. - It has an **established safety profile** in pregnancy across all trimesters and is considered safe by WHO and CDC. - While resistance has emerged in many areas for *P. falciparum*, chloroquine remains effective for *P. vivax* malaria in most regions including India. - For **severe malaria** or **chloroquine-resistant falciparum malaria**, alternative regimens like quinine or artesunate are used [1]. *Quinine* - **Quinine** (usually with clindamycin) is the preferred treatment for **severe malaria** or **chloroquine-resistant *P. falciparum*** malaria in pregnancy, especially in the **first trimester**. - It is safe and effective but can cause side effects like **cinchonism** (tinnitus, headache, nausea) and **hypoglycemia**. - While safe throughout pregnancy, it is not the first-line choice for uncomplicated chloroquine-sensitive malaria. *Primaquine* - **Primaquine** is **contraindicated in pregnancy** because it can cause **hemolytic anemia** in individuals with **G6PD deficiency**, and G6PD status of the fetus cannot be determined [3]. - It is used for **radical cure** of *P. vivax* and *P. ovale* to eliminate liver hypnozoites, but must be deferred until after delivery [3]. *Artesunate* - **Artesunate** and other **artemisinin-based combination therapies (ACTs)** are highly effective antimalarials [2]. - Current WHO guidelines support ACT use in all trimesters for severe malaria when benefits outweigh risks. - For **uncomplicated falciparum malaria**, ACTs are preferred in the **second and third trimesters** in areas with chloroquine resistance [2]. - However, chloroquine remains the classical "drug of choice" for uncomplicated, chloroquine-sensitive malaria in pregnancy [1].

Q: Drug of choice for Pneumocystis jirovecii in pregnancy?

Trimethoprim-sulfamethoxazole (SMZ/TMP). ***Trimethoprim-sulfamethoxazole (SMZ/TMP)*** - Despite being a **folate antagonist**, SMZ/TMP is considered safe and the **drug of choice** for treating **Pneumocystis jirovecii pneumonia (PJP)** in pregnant women, particularly as the benefits outweigh the risks. - It is recommended to supplement with **folic acid** during treatment to mitigate potential teratogenic risks, although these risks are generally low. *Primaquine* - **Primaquine** is primarily used for the treatment of **Plasmodium vivax** and **Plasmodium ovale malaria**, specifically targeting hypnozoites in the liver. - It is contraindicated in pregnancy due to the risk of **hemolytic anemia** in the fetus, especially if the fetus has **glucose-6-phosphate dehydrogenase (G6PD) deficiency**. *Dapsone* - **Dapsone** is used in the treatment of **leprosy**, **dermatitis herpetiformis**, and as an alternative for **PJP prophylaxis** in HIV-positive patients. - While it can be used for PJP prophylaxis, its efficacy for **active PJP treatment** is lower than SMZ/TMP, and it carries risks of **hemolytic anemia** and **methemoglobinemia**, particularly in pregnancy. *Pentamidine* - **Pentamidine** is an alternative treatment for **PJP**, especially in patients who cannot tolerate SMZ/TMP. - It is typically reserved for **severe cases** or as a second-line agent due to its potential for **significant toxicity**, including hypotension, nephrotoxicity, and hypoglycemia, which can be particularly concerning in pregnancy.

Q: Which antibiotic is primarily associated with Red man syndrome?

Vancomycin. **Vancomycin** - **Red man syndrome** is a well-known **infusion-related reaction** primarily associated with vancomycin. - It occurs due to the **rapid infusion** of vancomycin, leading to non-immunologic **mast cell degranulation** and histamine release. - Characterized by flushing, pruritus, and erythema of the upper body and face. - **Prevention:** Slow infusion rate (over 60 minutes or longer) and/or premedication with antihistamines. *Polymyxin B* - Polymyxin B is associated with **nephrotoxicity** and **neurotoxicity**, not typically with Red man syndrome. - It can cause **histamine release** leading to flushing and itching, but this is less common and less severe than with vancomycin. *Rifampicin* - Rifampicin is primarily known for causing **orange-red discoloration** of bodily fluids (e.g., urine, tears, sweat) and can cause **hepatotoxicity**, but not Red man syndrome. - It works by inhibiting bacterial **RNA synthesis** and is used to treat tuberculosis and other mycobacterial infections. *Teicoplanin* - Teicoplanin is a **glycopeptide antibiotic** similar to vancomycin, but it has a **significantly lower incidence** of Red man syndrome. - While it can cause some **infusion-related reactions**, they are generally milder and less frequent compared to vancomycin.

Q: What is the recommended dose of oseltamivir for a child aged 9 months?

3 mg/kg twice daily for 5 days. ***3 mg/kg twice daily for 5 days*** - For children aged **less than 1 year**, and weighing less than 15 kg, the recommended oseltamivir dose is **3 mg/kg** administered **twice daily** for 5 days. - This dosage regimen is effective in treating influenza and is based on studies of its **pharmacokinetics** and **efficacy** in this age group. *2 mg/kg twice daily for 5 days* - This dosage is **lower than recommended** for children under 1 year of age and may not achieve adequate therapeutic drug levels. - Subtherapeutic dosing could lead to **reduced antiviral efficacy** and potentially poorer clinical outcomes. *2.5 mg/kg twice daily for 5 days* - Similar to the 2 mg/kg dose, this is **below the standard recommendation** for infants and young children in this age bracket. - Inadequate dosing increases the risk of **treatment failure** and the development of **antiviral resistance**. *3.5 mg/kg twice daily for 5 days* - This dosage might be considered **higher than necessary** for a 9-month-old child and could potentially increase the risk of **adverse effects**. - While exact toxicities are rare within a reasonable range, adherence to recommended guidelines optimizes the **benefit-risk profile**.

Q: Which of the following drugs does not inhibit bacterial protein synthesis?

Sulfonamides. ***Sulfonamides*** - Sulfonamides do **NOT** inhibit bacterial protein synthesis; instead, they inhibit **folic acid synthesis**. - They act as **competitive inhibitors** of dihydropteroate synthase, an enzyme involved in the synthesis of dihydrofolic acid. - Folic acid is essential for nucleotide synthesis and DNA replication, making sulfonamides bacteriostatic agents that work through a completely different mechanism than protein synthesis inhibitors. *Aminoglycosides* - Aminoglycosides bind to the **30S ribosomal subunit**, causing misreading of mRNA and premature termination of protein synthesis. - This leads to the production of **abnormal and non-functional proteins**, ultimately killing the bacterial cell. *Chloramphenicol* - Chloramphenicol binds to the **50S ribosomal subunit**, thereby inhibiting the peptidyl transferase enzyme. - This prevents the formation of **peptide bonds** between amino acids, effectively blocking protein elongation. *Clindamycin* - Clindamycin also binds to the **50S ribosomal subunit**, specifically at the P-site. - It interferes with the **translocation step** of protein synthesis, preventing ribosomal movement along the mRNA.

Question 1

What is the mechanism of action of aminoglycoside antibiotics?

Accepted Answer

Inhibition of protein synthesis

Answer

Inhibition of DNA replication

Answer

Disruption of the cell membrane

Answer

Inhibition of bacterial cell wall synthesis

Question 2

What is the drug of choice for listeria meningitis?

Accepted Answer

Ampicillin

Answer

Cefotaxime

Answer

Ciprofloxacin

Answer

Ceftriaxone

Question 3

All of the following are used for treatment of *H. pylori*, except:

Accepted Answer

Gentamicin

Answer

Metronidazole

Answer

Amoxicillin

Answer

Clarithromycin

Question 4

Which of the following medications is not typically used in the treatment of malignant malaria?

Accepted Answer

Quinolone

Answer

Doxycycline

Answer

Artesunate

Answer

Quinine

Question 5

What is the drug of choice for malaria in pregnancy?

Accepted Answer

Chloroquine

Answer

Primaquine

Answer

Artesunate

Answer

Quinine

Question 6

Drug of choice for Pneumocystis jirovecii in pregnancy?

Accepted Answer

Trimethoprim-sulfamethoxazole (SMZ/TMP)

Answer

Primaquine

Answer

Dapsone

Answer

Pentamidine

Question 7

What is the best skin disinfectant for central line insertion?

Accepted Answer

Chlorhexidine

Answer

Alcohol

Answer

Cetrimide

Answer

Povidone iodine

Question 8

Which antibiotic is primarily associated with Red man syndrome?

Accepted Answer

Vancomycin

Answer

Polymyxin B

Answer

Rifampicin

Answer

Teicoplanin

Question 9

What is the recommended dose of oseltamivir for a child aged 9 months?

Accepted Answer

3 mg/kg twice daily for 5 days

Answer

2 mg/kg twice daily for 5 days

Answer

2.5 mg/kg twice daily for 5 days

Answer

3.5 mg/kg twice daily for 5 days

Question 10

Which of the following drugs does not inhibit bacterial protein synthesis?

Accepted Answer

Sulfonamides

Answer

Aminoglycosides

Answer

Chloramphenicol

Answer

Clindamycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?